FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P160049
·
Supplement: S018
·
Decision Jun 22, 2022
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- Stellarex 035 Drug Coated Ballon Percutaneous Transluminal Angioplasty Catheter
- PMA Number
- P160049
- Supplement Number
- S018
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 22, 2022
- Date Received
- April 1, 2022
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for a manufacturing site located at Philips Image Guided Therapy Corporation, 5905 Nathan Lane North, Plymouth, MN 55442 for catheter assembly of the Stellarex 035 Drug Coated Balloon.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |